2019
DOI: 10.1159/000496348
|View full text |Cite
|
Sign up to set email alerts
|

Atrial Septal Defect Sizing and Transcatheter Closure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 9 publications
0
5
0
Order By: Relevance
“…However, the current analysis of and theory on how device erosion occurs have signi cant limitations. Therefore, we should pay attention to the following points in future transcatheter closure: rst, we should rigorously identify the indications before the operation; second, we must improve transthoracic echocardiography and transesophageal echocardiography before the operation to preoperatively assess the morphology of the ASD with respect to its location, size, shape, and margins and select the appropriate occluder according to the examination results; third, since events are more frequent in the rst year, there should be frequent follow-up in the rst year (e.g., serial echocardiography at 1 week, 1 month, 3 months, and 6 months) and clinical follow-up annually with less frequent follow-up after the rst year [9]; fourth, clinicians must ensure that patients are well informed of the risks/bene ts of transcatheter closure of ASD. Further, su cient communication between clinicians and their patients who have undergone implantation should be occur to educate patients about symptoms without creating fear and anxiety.…”
Section: Discussionmentioning
confidence: 99%
“…However, the current analysis of and theory on how device erosion occurs have signi cant limitations. Therefore, we should pay attention to the following points in future transcatheter closure: rst, we should rigorously identify the indications before the operation; second, we must improve transthoracic echocardiography and transesophageal echocardiography before the operation to preoperatively assess the morphology of the ASD with respect to its location, size, shape, and margins and select the appropriate occluder according to the examination results; third, since events are more frequent in the rst year, there should be frequent follow-up in the rst year (e.g., serial echocardiography at 1 week, 1 month, 3 months, and 6 months) and clinical follow-up annually with less frequent follow-up after the rst year [9]; fourth, clinicians must ensure that patients are well informed of the risks/bene ts of transcatheter closure of ASD. Further, su cient communication between clinicians and their patients who have undergone implantation should be occur to educate patients about symptoms without creating fear and anxiety.…”
Section: Discussionmentioning
confidence: 99%
“…[ 35 ] Accurate sizing’s significance in transcatheter ASD closure was underscored, particularly guided by echocardiography and imaging techniques to ensure optimal procedural outcomes. [ 36 ] A broader perspective on ASD closure emerged in a commentary, acknowledging transcatheter advancements while emphasizing ongoing research to refine patient selection criteria and improve outcomes. [ 37 ] In addition, transcatheter closure benefits were discussed in a study, highlighting the technique’s minimally invasive advantages.…”
Section: A Trial S Eptal D ...mentioning
confidence: 99%
“…In the final phase of the procedure, a test is performed to check the stability of the implanted clasp. After obtaining a positive test result, the delivery system is detached [11]. The guidelines of the European Society of Cardiology (ESC) from 2020 recommend closure of secondary defects in patients with a significant left-to-right shunt.…”
Section: Therapeutic Managementmentioning
confidence: 99%